
Join to View Full Profile
4501 X StSacramento, CA 95817
Phone+1 916-734-8252
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Zelanna Goldberg, MD is a radiation oncologist in Sacramento, California. She is currently licensed to practice medicine in California.
Education & Training
University of Toronto Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1998 - 2026
Clinical Trials
- Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- 49 citationsCombined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non–Small Cell Lung Cancer: Results of a Phase I StudyPasi A. Jänne, Alice T. Shaw, D. Ross Camidge, Giuseppe Giaccone, S. Martin Shreeve
Journal of Thoracic Oncology. 2016-05-01 - 18 citationsEffect of food or proton pump inhibitor treatment on the bioavailability of dacomitinib in healthy volunteersAna Ruiz-Garcia, Joanna C. Masters, Laure Mendes da Costa, Robert R. LaBadie, Yali Liang
Journal of Clinical Pharmacology. 2016-02-01 - 254 citationsTargeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or a...Mark G. Kris, D.R. Camidge, Giuseppe Giaccone, Toyoaki Hida, Bob T. Li
Annals of Oncology. 2015-07-01
Press Mentions
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsAugust 10th, 2021
Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. As Chief Medical OfficerJune 2nd, 2021









